For now, our advice on this forum is for a 4th generation test (same thing as duo test) at 4 weeks for definitive result.
A related discussion,
Testing Window for NYC was started.
MedHelp exercises no control at all over the community forums. There are no formal moderators -- the people who particpate frquently are generally knowledgeable, altruistic, and helpful. But everything they say and do is entirely on their own. We have no way to dictate their perspectives and advice.
I agree with you (that a DUO test @ 4 weeks is definitive). I wish you could get the HIV Prevention on board with that so there is consistency.
Yeah, I plan to do that anyway for peace of mind.
Likely he'll state that the 28 day test is definitive. Especially if it is a DUO ab/ag test. No less you are using condoms for vaginal/anal sex.
Thank you for your response. It's great to see you have worked with the CDC on these matters, which makes me that much more happy I came to you with this question.
As a quick follow up. In your opinion. Should I stick with a 28 day post exposure fourth generation testing until those formal recommendations come out? I'm a heterosexual male. Use condoms for vaginal sex but not for oral.
Welcome to the forum. Thanks for your question and for the opportunity to comment on potential evolving recommendations on HIV testing. This is an area I know something about; take a look at the author list on CDC's current (2006) national recommendations for HIV screening:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm
It is correct that CDC is soon expected to officially role out a "new algorithm" for HIV testing policies and procedures, and the July MMWR report (the last of the URLs you have listed) goes into some detail about what to expect. Thanks for letting me know that the Massachusetts health department is already citing evidence in favor of earlier definitive results for HIV testing; I was unaware of it.
That said, the CDC algorithm probably will not be a one-size-fits-all recommenation. The whole point of an algorithm is to provide decision points that branch in different ways, depending on the clinical situation, prior risk, results of initial testing, and the like. For example, the approach may end up being different following an especially high risk exposure, or when symptoms suggest ARS in someone at high risk, compared with general screening when someone is at risk but there is no concern about any particular exposure (which is how most HIV testing is done, i.e. not because of a specific exposure).
We will all need to patiently wait until CDC officially comes out with its new recommendations and algorithm(s). However, I suspect they will include testing beyond 2 weeks in some patients with negative duo tests at that time. Another issue is that labs in the United States have been slow to transition to the duo for routine testing. Perhaps new algorithm(s) and/or guidelines will speed that process, but it won't happen overnight.
Best regards-- HHH, MD